{"id":175983,"date":"2026-07-29T10:14:49","date_gmt":"2026-07-29T04:44:49","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=175983"},"modified":"2026-07-29T10:14:49","modified_gmt":"2026-07-29T04:44:49","slug":"divi-s-laboratories-ltd-share-price-52-week-high-2026-07-29","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-ltd-share-price-52-week-high-2026-07-29\/","title":{"rendered":"Divi&#8217;s Laboratories Ltd. (DIVISLAB) Share Price Hits New 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;;margin-top:0!important;margin-bottom:0!important;\">Divi&#8217;s Laboratories Ltd. Share Price has reached a fresh 52-week high, closing at Rs 7,565.25, marking a 1.95% increase from the previous close of Rs 7,420.45. The stock opened at Rs 7,437.3 and reached a high of Rs 7,585.5 during the day. The company&#8217;s market capitalisation now stands at Rs 1,96,880.79 crore. This surge in price highlights the stock&#8217;s strong performance in the market, capturing investor attention.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Divis_Laboratories_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Divi&#8217;s Laboratories Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,565.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,420.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 144.8 (+1.95%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,437.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,585.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,437.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4,274<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,96,880.79 crore<\/td>\n<\/tr>\n<\/table>\n<p style=\"margin-top:0!important;\">Today, Divi&#8217;s Laboratories Ltd. Share Price opened at Rs 7,437.3 and climbed to a high of Rs 7,585.5, setting a new 52-week high. The stock closed at Rs 7,565.25, up by Rs 144.8 or 1.95% from the previous close. The day&#8217;s low was also the opening price, indicating a strong upward movement throughout the trading session. The turnover for the day was Rs 3.23 crore with a volume of 4,274 shares, reflecting moderate trading activity.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Divis_Laboratories_Ltd_DIVISLAB_Fundamental_Analysis\"><\/span><strong>Divi&#39;s Laboratories Ltd. (DIVISLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,96,880.79 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.31x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.43x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<\/table>\n<p>Divi&#39;s Laboratories Ltd. was valued at a P\/E ratio of 29.31x, a P\/B ratio of 0.43x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.31x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.06x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">68.59x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,439.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.43x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.91%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,96,880.79 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 140.64 crore<\/td>\n<\/tr>\n<\/table>\n<p>Divi&#39;s Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare. The numerical benchmark uses 198 same sector companies from the supplied master-data set.<\/p>\n<p>Divi&#39;s Laboratories Ltd. (DIVISLAB) has a P\/E ratio of 29.31x, which is above the benchmark median of 21.06x, a difference of +39.17%. The benchmark contains 198 companies with P\/E data, ranging from 0x to 3,439.3x. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Divi&#39;s Laboratories Ltd. (DIVISLAB) has a ROE of -2.89%, which is below the benchmark median of 10.91%, a difference of -126.49%. Divi&#39;s Laboratories Ltd. (DIVISLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.2%, a difference of -101.97%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,921.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,815.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,476.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">169.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,472.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">56.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,444.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<\/table>\n<p>Divi&#39;s Laboratories Ltd. (DIVISLAB) has a P\/E ratio of 29.31x compared with the displayed peer median of 39.89x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Divi&#39;s Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 1,96,880.79 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Divis_Laboratories_Ltd\"><\/span><strong>Why Investors Are Watching Divi&#8217;s Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Divi&#8217;s Laboratories Ltd. Share Price reached a new 52-week high, indicating strong market interest.<\/li>\n<li>The stock&#8217;s P\/E ratio is above the sector median, suggesting a relatively higher valuation.<\/li>\n<li>Despite negative ROE and ROCE, the company maintains a large market cap.<\/li>\n<li>The Healthcare sector&#8217;s wide valuation range provides context for the stock&#8217;s performance.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Divis_Laboratories_Ltd\"><\/span><strong>About Divi&#8217;s Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Divi&#8217;s Laboratories Ltd. is a prominent player in the Healthcare sector, focusing on the production of active pharmaceutical ingredients (APIs) and intermediates. The company serves a global clientele, providing high-quality products for various therapeutic areas. With a strong emphasis on research and development, Divi&#8217;s Laboratories Ltd. continues to innovate and expand its product portfolio, maintaining a competitive edge in the industry.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Divis_Laboratories_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Divi&#8217;s Laboratories Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\">Divi&#39;s Laboratories Ltd. (DIVISLAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors can track Divi&#8217;s Laboratories Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest. Stay informed about the latest developments and market trends.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Divis_Laboratories_Ltd\"><\/span><strong>What is the current share price of Divi&#39;s Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current share price of Divi&#39;s Laboratories Ltd. is Rs 7,565.25, marking a fresh 52-week high. The stock has shown a 1.95% increase from the previous close. The stock moved 1.95% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Divis_Laboratories_Ltd\"><\/span><strong>What is the market capitalisation of Divi&#39;s Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The market capitalisation of Divi&#39;s Laboratories Ltd. is Rs 1,96,880.79 crore, reflecting its significant size within the Healthcare sector. The company operates in the Healthcare sector. Its P\/E ratio is 29.31x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Divis_Laboratories_Ltd\"><\/span><strong>What is the P\/E ratio of Divi&#39;s Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#39;s Laboratories Ltd. has a P\/E ratio of 29.31, which is above the sector median of 21.06, indicating a higher valuation relative to many peers. The company trades at a P\/E ratio of 29.31x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Divis_Laboratories_Ltd_compare_to_its_peers\"><\/span><strong>How does Divi&#39;s Laboratories Ltd. compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#39;s Laboratories Ltd. has a larger market cap compared to peers like Dishman Carbogen Amcis Ltd. and Kwality Pharmaceuticals Ltd., but it has negative ROE and ROCE. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Sai Parenteral&#39;s.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Divis_Laboratories_Ltd_operate_in\"><\/span><strong>What sector does Divi&#39;s Laboratories Ltd. operate in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#39;s Laboratories Ltd. operates in the Healthcare sector, focusing on the production of active pharmaceutical ingredients and intermediates. The stock belongs to the Healthcare sector. 198 comparable companies were included in the benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_ROE_and_ROCE_of_Divis_Laboratories_Ltd\"><\/span><strong>What are the ROE and ROCE of Divi&#39;s Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#39;s Laboratories Ltd. has a negative ROE of -2.89% and ROCE of -0.26%, indicating challenges in profitability and capital efficiency. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.91%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PB_ratio_of_Divis_Laboratories_Ltd\"><\/span><strong>What is the P\/B ratio of Divi&#39;s Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/B ratio of Divi&#39;s Laboratories Ltd. is 0.43, significantly lower than the sector median of 1.88, suggesting potential undervaluation. The company trades at a P\/E ratio of 29.31x. Its P\/B ratio is 0.43x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_sector_median_PE_ratio\"><\/span><strong>What is the sector median P\/E ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The sector median P\/E ratio for the Healthcare sector is 21.06, providing a benchmark for evaluating Divi&#39;s Laboratories Ltd.&#39;s valuation. The company trades at a P\/E ratio of 29.31x. Its P\/B ratio is 0.43x.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Divi&#8217;s Laboratories Ltd. Share Price hits a new 52-week high at Rs 7,565.25. marking a 1.95% rise today. Market cap stands at Rs 1,96,880.79 crore.<\/p>\n","protected":false},"author":29,"featured_media":175982,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-175983","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["175982"],"rank_math_title":["Divi's Laboratories Ltd. Share Price Hits New 52-Week High"],"rank_math_description":["Divi's Laboratories Ltd. Share Price hits a fresh 52-week high at Rs 7,565.25. Explore price action, fundamentals, and sector analysis."],"rank_math_focus_keyword":["Divi's Laboratories Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Divis_Laboratories_Ltd_DIVISLAB_Share_Price_Hits_New_52_Week_High_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/175983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=175983"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/175983\/revisions"}],"predecessor-version":[{"id":175984,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/175983\/revisions\/175984"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/175982"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=175983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=175983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=175983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}